Additionally, various studies have shown that SAA contributes to cancer progression through the promotion of proliferation, metastasis, inflammation and angiogenesis in breast, lung, prostate, ovarian and renal cell cancers (4, 8–11). The gene discussed is SAA2; the disease is cancer.